References
World Health Organization (WHO). WHODirector-General’s opening remarks at the media briefing on COVID-19-11 March 2020. Ginebra: WHO; 2020. [citado 2020 May 30]. Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.
Aydemir D, Ulusu NN. Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic. Biotechnol App Biochem. 2020. https://doi.org/10.1002/bab.1936.
Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6. https://doi.org/10.1007/s12098-020-03263-6.
Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID?19 infection. Am J Hematol. 2020;95(6):E131-4. https://doi.org/10.1002/ajh.25774.
Zhang L, Yan X, Fan Q, Liu H, Liu X Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid19. J Thromb Haemost. 2020;18(6):1324-9 https://doi.org/10.1111/jth.14859.
Ferrnari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem LabMed. 2020;58(7):1095-9. https://doi.org/10.1515/cclm-2020-0398.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052?9. https://doi.org/10.1001/jama.2020.6775.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. https://doi.org/10.1007/s00392-020-01626-9.